Literature DB >> 17560207

Maternal microchimerism in biliary atresia.

Hiroyuki Kobayashi1, Takuya Tamatani, Tsuyoshi Tamura, Junichi Kusafuka, Atsuyuki Yamataka, Geoffrey J Lane, Seiji Kawasaki, Yoichi Ishizaki, Koichi Mizuta, Hideo Kawarasaki, George K Gittes.   

Abstract

BACKGROUND: The aim of this study was to determine the existence and extent of maternal microchimerism in the livers of biliary atresia (BA) patients.
METHODS: Two series of investigations were performed based on the sex of our subjects. Subjects for series I were men, of which 6 had BA. Livers were analyzed using X and Y chromosome probes and fluorescent in situ hybridization. Subjects for series II were woman. Nine BA cases and their mothers were HLA typed (class I). Daughter livers were also tested for antibodies to maternal and other HLA. Two cases of neonatal hepatitis, 2 cases of Alagille syndrome, and 1 case of Byler syndrome acted as controls.
RESULTS: All male BA livers were found to contain a mixture of cells with 1 and 2 X chromosomes (ie, XY or XX). All livers from male controls had only 1 X chromosome (ie, XY). All female BA subjects had varying intensities of antimaternal HLA class I (HLA-A) antibodies in their bile duct epithelium and hepatocytes (strong, 5; mild, 3; weak, 1). The liver from the female control did not display any antimaternal HLA class I antibodies (HLA-Ab).
CONCLUSION: Our preliminary data appear to show that maternal microchimerism is present within the livers of patients with progressive postnatal type BA. We suggest that BA could in fact be a graft-vs-host disease masquerading as an autoimmune reaction triggered by maternal microchimerism, and we intend to pursue this hypothesis further to clarify the etiology of BA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560207     DOI: 10.1016/j.jpedsurg.2007.01.051

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  16 in total

1.  Maternal microchimerism in patients with biliary atresia: Implications for allograft tolerance.

Authors:  Amar Nijagal; Shannon Fleck; Tippi C MacKenzie
Journal:  Chimerism       Date:  2012-04-01

Review 2.  Maternal microchimerism in biliary atresia: are maternal cells effector cells, targets, or just bystanders?

Authors:  Toshihiro Muraji
Journal:  Chimerism       Date:  2014-03-26

Review 3.  Maternal-fetal cellular trafficking: clinical implications and consequences.

Authors:  Cerine Jeanty; S Christopher Derderian; Tippi C Mackenzie
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

4.  Alterations in maternal-fetal cellular trafficking after fetal surgery.

Authors:  Payam Saadai; Tzong-Hae Lee; Geoanna Bautista; Kelly D Gonzales; Amar Nijagal; Michael P Busch; Chong Jai Kim; Roberto Romero; Hanmin Lee; Shinjiro Hirose; Larry Rand; Douglas Miniati; Diana L Farmer; Tippi C MacKenzie
Journal:  J Pediatr Surg       Date:  2012-06       Impact factor: 2.545

5.  The maternal immune response inhibits the success of in utero hematopoietic cell transplantation.

Authors:  Amar Nijagal; Marta Wegorzewska; Tom Le; Qizhi Tang; Tippi C Mackenzie
Journal:  Chimerism       Date:  2011-04

Review 6.  Cholestatic liver disease in children.

Authors:  Jorge L Santos; Monique Choquette; Jorge A Bezerra
Journal:  Curr Gastroenterol Rep       Date:  2010-02

Review 7.  Naturally acquired microchimerism.

Authors:  Hilary S Gammill; J Lee Nelson
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

Review 8.  Biliary atresia.

Authors:  Giorgina Mieli-Vergani; Diego Vergani
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 9.  Women and primary biliary cirrhosis.

Authors:  Ying Sun; Krista Haapanen; Baosen Li; Weici Zhang; Judy Van de Water; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 10.  Unique manifestations of biliary atresia provide new immunological insight into its etiopathogenesis.

Authors:  Toshihiro Muraji; Haruo Ohtani; Satoshi Ieiri
Journal:  Pediatr Surg Int       Date:  2017-10-11       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.